By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Inform Genomics 

101 Federal Street, Suite 1900

Boston  Massachusetts  02110  U.S.A.
Phone: n/a Fax: n/a



Company News
Inform Genomics Files Provisional Patent Application With United States Patent And Trademark Office (USPTO) -"Systems And Methods For Predicting Treatment-Regimen-Related Outcomes." 10/5/2015 7:25:09 AM
Inform Genomics Selects ICON As Contract Research Organization (CRO) For Pivotal Multicenter Study Of HSCT/Mucositis Product Candidate 6/1/2015 9:13:50 AM
Inform Genomics Licenses Two US Patents From Taiwan's National Cheng Kung University Medical College To Advance Development Of Precision Medicine Products 6/1/2015 8:26:18 AM
Inform Genomics Selects US Oncology Research As The Site Management Organization (SMO) For Pivotal Multicenter Study Of Onpart 5/29/2015 3:12:19 PM
Inform Genomics Selects Vector Oncology As Contract Research Organization (CRO) For Pivotal Multicenter Study Of OnPART 5/29/2015 1:16:42 PM
Inform Genomics Announces Appointment Of Carl De Moor, Phd, As Chief Technology Officer 7/28/2014 8:19:03 AM
Inform Genomics And Translational Drug Development (TD2) Announce Strategic Collaboration 6/23/2014 7:34:20 AM
Inform Genomics Presents Biologic Validity for OnPART Predictive Networks Identifying Potential Genomic Targets for Drug Discovery 6/3/2013 9:14:29 AM
Inform Genomics Presents Results for OnPART™ Showing High Degree of Accuracy Predicting Six Common Side Effects of FOLFOX Chemotherapy for Colon Cancer 1/28/2013 9:11:32 AM
Inform GenomicsTransplant Product Shown to Predict Oral Mucositis with a High Degree of Accuracy in Patients Undergoing Conditioning Regimens Prior to Hematopoetic Stem Cell Transplant 12/11/2012 10:03:22 AM